Stem cell transplants may have long-lasting benefits for some people with aggressive cases of multiple sclerosis, a new study suggests. Italian researchers found that among 210 multiple sclerosis (MS) patients who received a stem cell transplant — with cells from their own blood — two-thirds saw no worsening in their disability 10 years out. That included 71% of patients with relapsing-remitting MS, the most common form of the disease. The sustained level of effectiveness is “pretty dramatic,” said Bruce Bebo, executive vice-president of research programs for the National Multiple Sclerosis Society. At the same time, there are important caveats, said Bebo, who was not involved in the study. For one, the patients were not part of a clinical trial that directly tested stem cell transplants against standard MS medications. They all underwent transplants at various Italian medical centers between 1997 and 2019. So it’s unclear exactly how such transplants measure up against the most effective MS drugs now available. Beyond that, Bebo said there are ongoing questions about which MS patients are the best candidates for a transplant, and the optimal timing for it. Those are no small matters, since a stem cell transplant is a major undertaking, he pointed out. “And it’s not reversible, like a medication you can change when it’s not working,” Bebo said. MS is a neurological disorder caused by a… read on > read on >
A little about: Weekly Gravy
All Sauce from Weekly Gravy:
Premature Menopause May Bring Tougher Symptoms for Women
Menopause is known to bring a variety of unpleasant symptoms ranging from hot flashes to insomnia. Yet, for those who have a condition known as premature ovarian insufficiency (POI), it is much worse, researchers report. The new study examined the impact of POI, in which ovarian function stops and leads to menopause before the age of 40. The researchers investigated menopause symptoms in women with POI and compared them with the severity and prevalence of similar symptoms in women who experienced natural menopause. The study included nearly 300 women. The investigators found that women with POI experience a high prevalence of menopause symptoms, especially psychological and sexual symptoms. This included mood swings, hot flashes, insomnia, fatigue and sexual dysfunction, such as vaginal dryness, painful intercourse and decreased libido. These symptoms are often more severe than those experienced by women who undergo natural menopause. “This study of Chinese women showed that those with POI had more prevalent menopause-related symptoms than women with menopause at the average age,” Dr. Stephanie Faubion, medical director for the North American Menopause Society, said in a society news release. “It is important to note that, regardless of the prevalence or severity of symptoms, women with POI should receive hormone therapy at least until the average age of menopause unless there are contraindications to its use, in order to mitigate potential long-term… read on >
Arthritis Drug Tocilizumab Flops as COVID-19 Treatment
The arthritis drug tocilizumab doesn’t help hospital patients with severe COVID-19, according to a new study that contradicts earlier research suggesting that it might aid recovery. In fact, patients receiving tocilizumab had a higher risk of death, so the trial was halted early. Tocilizumab blocks a part of the immune system (interleukin 6) that can become overactive in some COVID-19 patients, and it was thought that the drug might help reduce inflammatory responses in patients. That theory was tested in this study, which included 129 adult COVID-19 patients, average age 57, at nine hospitals in Brazil. They had abnormal levels of at least two inflammation-related compounds in their blood and were receiving supplemental oxygen or mechanical ventilation. The patients were randomly selected to receive either tocilizumab plus standard care (65) or standard care alone (64). After 15 days, 18 (28%) of the patients in the tocilizumab group and 13 (20%) of those in the standard care group were on mechanical ventilation or had died. Eleven (17%) of the patients in the tocilizumab group died, compared with 2 (3%) in the standard care group. Due to the much higher death rate in the tocilizumab group, the trial was stopped early. In both groups of patients, deaths were due to COVID-19-related acute respiratory failure or multiple organ dysfunction. The findings were published Jan. 20 in the BMJ… read on > read on >
Could Stem Cell Therapy Be a Breakthrough Against MS?
Stem cell transplants may have long-lasting benefits for some people with aggressive cases of multiple sclerosis, a new study suggests. Italian researchers found that among 210 multiple sclerosis (MS) patients who received a stem cell transplant — with cells from their own blood — two-thirds saw no worsening in their disability 10 years out. That included 71% of patients with relapsing-remitting MS, the most common form of the disease. The sustained level of effectiveness is “pretty dramatic,” said Bruce Bebo, executive vice-president of research programs for the National Multiple Sclerosis Society. At the same time, there are important caveats, said Bebo, who was not involved in the study. For one, the patients were not part of a clinical trial that directly tested stem cell transplants against standard MS medications. They all underwent transplants at various Italian medical centers between 1997 and 2019. So it’s unclear exactly how such transplants measure up against the most effective MS drugs now available. Beyond that, Bebo said there are ongoing questions about which MS patients are the best candidates for a transplant, and the optimal timing for it. Those are no small matters, since a stem cell transplant is a major undertaking, he pointed out. “And it’s not reversible, like a medication you can change when it’s not working,” Bebo said. MS is a neurological disorder caused by a… read on > read on >
Now That Psychiatric Care Has Gone Online, Many Patients Want It to Stay There
Only a year ago, Michigan Medicine psychiatrists were trying to recruit patients to give telepsychiatry a try, with very little success. The psychiatrists worked with people by video only 26 times in six months, while 30,000 visits happened in person. But that changed quickly when the coronavirus pandemic forced closures in the area in late March. Now, not only have patients seeking help with mental health issues been working through their emotions and experiences by video and phone for months — many would like to keep those options, a new study shows. “Telepsychiatry is an interesting tool for various reasons in terms of providing early access to care, connecting patients in rural areas or who live far away from clinics to be able to get good evidence-based care,” said study author Dr. Jennifer Severe, a psychiatrist who helped launch a test of telehealth initiatives at the University of Michigan’s outpatient psychiatry clinic. “Even patients who are closer, based on life burden and expectation, they might not be able to keep up with their appointments, so telehealth actually offers a way to remain connected with care, regardless of how busy people’s lives might be,” Severe said. For the study, published recently in the journal JMIR Formative Research, researchers surveyed 244 patients or parents of minor patients in summer 2020. The patients had mental health appointments in… read on > read on >
Premature Menopause May Bring Tougher Symptoms for Women
Menopause is known to bring a variety of unpleasant symptoms ranging from hot flashes to insomnia. Yet, for those who have a condition known as premature ovarian insufficiency (POI), it is much worse, researchers report. The new study examined the impact of POI, in which ovarian function stops and leads to menopause before the age of 40. The researchers investigated menopause symptoms in women with POI and compared them with the severity and prevalence of similar symptoms in women who experienced natural menopause. The study included nearly 300 women. The investigators found that women with POI experience a high prevalence of menopause symptoms, especially psychological and sexual symptoms. This included mood swings, hot flashes, insomnia, fatigue and sexual dysfunction, such as vaginal dryness, painful intercourse and decreased libido. These symptoms are often more severe than those experienced by women who undergo natural menopause. “This study of Chinese women showed that those with POI had more prevalent menopause-related symptoms than women with menopause at the average age,” Dr. Stephanie Faubion, medical director for the North American Menopause Society, said in a society news release. “It is important to note that, regardless of the prevalence or severity of symptoms, women with POI should receive hormone therapy at least until the average age of menopause unless there are contraindications to its use, in order to mitigate potential long-term… read on >
Arthritis Drug Tocilizumab Flops as COVID-19 Treatment
The arthritis drug tocilizumab doesn’t help hospital patients with severe COVID-19, according to a new study that contradicts earlier research suggesting that it might aid recovery. In fact, patients receiving tocilizumab had a higher risk of death, so the trial was halted early. Tocilizumab blocks a part of the immune system (interleukin 6) that can become overactive in some COVID-19 patients, and it was thought that the drug might help reduce inflammatory responses in patients. That theory was tested in this study, which included 129 adult COVID-19 patients, average age 57, at nine hospitals in Brazil. They had abnormal levels of at least two inflammation-related compounds in their blood and were receiving supplemental oxygen or mechanical ventilation. The patients were randomly selected to receive either tocilizumab plus standard care (65) or standard care alone (64). After 15 days, 18 (28%) of the patients in the tocilizumab group and 13 (20%) of those in the standard care group were on mechanical ventilation or had died. Eleven (17%) of the patients in the tocilizumab group died, compared with 2 (3%) in the standard care group. Due to the much higher death rate in the tocilizumab group, the trial was stopped early. In both groups of patients, deaths were due to COVID-19-related acute respiratory failure or multiple organ dysfunction. The findings were published Jan. 20 in the BMJ… read on > read on >
Could Stem Cell Therapy Be a Breakthrough Against MS?
Stem cell transplants may have long-lasting benefits for some people with aggressive cases of multiple sclerosis, a new study suggests. Italian researchers found that among 210 multiple sclerosis (MS) patients who received a stem cell transplant — with cells from their own blood — two-thirds saw no worsening in their disability 10 years out. That included 71% of patients with relapsing-remitting MS, the most common form of the disease. The sustained level of effectiveness is “pretty dramatic,” said Bruce Bebo, executive vice-president of research programs for the National Multiple Sclerosis Society. At the same time, there are important caveats, said Bebo, who was not involved in the study. For one, the patients were not part of a clinical trial that directly tested stem cell transplants against standard MS medications. They all underwent transplants at various Italian medical centers between 1997 and 2019. So it’s unclear exactly how such transplants measure up against the most effective MS drugs now available. Beyond that, Bebo said there are ongoing questions about which MS patients are the best candidates for a transplant, and the optimal timing for it. Those are no small matters, since a stem cell transplant is a major undertaking, he pointed out. “And it’s not reversible, like a medication you can change when it’s not working,” Bebo said. MS is a neurological disorder caused by a… read on > read on >
Stressed Out By the News? Here’s Tips to Help Cope
Be kind to your heart and health and turn off the news, doctors say. Northwestern University experts suggest checking in on current events a couple of times a day and no more. Constant updates can fuel anxiety and depression, they warn. “As a practicing preventive cardiologist, one of the most common risk factors for heart disease that I am seeing this year is stress,” said Dr. Sadiya Khan, assistant professor of cardiology and epidemiology at Northwestern University Feinberg School of Medicine in Chicago. “I know we can all agree it has been an extremely stressful year for all in every aspect of our lives, including stress related to the pandemic and associated health, financial and political events.” Constant news updates pile on layer upon layer of stress, according to Dr. Aderonke Pederson, a psychiatrist at Northwestern Medicine. “That cumulative stress can translate into increased risks of heart problems, diabetes and more,” she said. “Mental illnesses like depression and anxiety, especially when untreated, can increase your risk for chronic health conditions like diabetes, cardiac events and heart disease and can complicate symptoms of asthma. So, there’s a feedback loop of mental health conditions and physical health conditions.” The doctors offered several coping strategies, including getting a good night’s sleep and calming your mind a couple hours before bedtime with a light-hearted book, journaling, playing a game… read on > read on >
Now That Psychiatric Care Has Gone Online, Many Patients Want It to Stay There
Only a year ago, Michigan Medicine psychiatrists were trying to recruit patients to give telepsychiatry a try, with very little success. The psychiatrists worked with people by video only 26 times in six months, while 30,000 visits happened in person. But that changed quickly when the coronavirus pandemic forced closures in the area in late March. Now, not only have patients seeking help with mental health issues been working through their emotions and experiences by video and phone for months — many would like to keep those options, a new study shows. “Telepsychiatry is an interesting tool for various reasons in terms of providing early access to care, connecting patients in rural areas or who live far away from clinics to be able to get good evidence-based care,” said study author Dr. Jennifer Severe, a psychiatrist who helped launch a test of telehealth initiatives at the University of Michigan’s outpatient psychiatry clinic. “Even patients who are closer, based on life burden and expectation, they might not be able to keep up with their appointments, so telehealth actually offers a way to remain connected with care, regardless of how busy people’s lives might be,” Severe said. For the study, published recently in the journal JMIR Formative Research, researchers surveyed 244 patients or parents of minor patients in summer 2020. The patients had mental health appointments in… read on > read on >